Pelago Bioscience
Pelago Bioscience facts
Sector
Specialist Pharma Services
Impilo entry date
August 2023
HQ
Solna, Sweden
Management team
Michael Dabrowski (CEO)
Kia Pedersen (COO)
Impilo team
Victor Steien
Magnus Edlund
Edvard Hubendick
Paula Johansson
No of employees
46
Investment thesis
- Sizeable market growing at 10%+ p.a. driven by increasing drug development pipelines, enhanced complexity in novel compound-design and shift towards outsourcing
- Unique value proposition (patented CETSA technology) and an opportunity to capture market share
- Scope to drive M&A in the drug discovery space to accelerate expansion and complement service offering
UN SDG Goals
Other portfolio companies
MedTech
Qufora
Qufora is a fast-growing Danish medical technology product company with focus on transanal irrigation (“TAI”) products and collecting devices
Read More
Pharmaceuticals
Avia Pharma
Avia is a leading North European OTC/Rx platform
Read More
MedTech
Stille
Stille is a well-established pioneer in the development of premium surgical instruments and advanced surgical tables
Read More